PDE9A and cancer: PDE9A decreases PKG activity through the hydrolysis of cGMP, whereas the stimulation of cGMP/PKG signaling can suppress Wnt/β-catenin transcription, inhibit the proliferation of cancer cells, and enhance tumor immunity [35].